Robert Dunham Short's most recent trade in Virnetx Holding Corp was a trade of 50 Common Stock done at an average price of $12.3 . Disclosure was reported to the exchange on July 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Virnetx Holding Corp | Robert Dunham Short | Chief Scientist | 07 Jul 2025 | 50 | 31,848 (0%) | 0% | 12.3 | 617 | Common Stock | |
| Virnetx Holding Corp | Robert Dunham Short | Chief Scientist | 23 Jun 2025 | 8 | 31,898 (0%) | 0% | 8 | 64 | Common Stock | |
| Virnetx Holding Corp | Robert Dunham Short | Chief Scientist | 12 Nov 2024 | 30,000 | 31,906 (0%) | 0% | 0 | Common Stock | ||
| Virnetx Holding Corp | Robert Dunham Short | Director, Chief Scientist | 07 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option(Right to Buy) | ||
| Virnetx Holding Corp | Robert Dunham Short | Director, Chief Scientist | 07 Jun 2022 | 13,336 | 46,670 (0%) | 0% | 0 | Common Stock | ||
| Virnetx Holding Corp | Robert Dunham Short | Director, CTO and Chief Scientist | 14 Jun 2021 | 44,000 | 44,000 | - | - | Stock Option(Right to Buy) | ||
| Virnetx Holding Corp | Robert Dunham Short | Director, CTO and Chief Scientist | 14 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option(Right to Buy) | ||
| Virnetx Holding Corp | Robert Dunham Short | Director, CTO and Chief Scientist | 14 Jun 2021 | 13,333 | 134,256 (0%) | 0% | 0 | Common Stock |